Indeed, increased glucose uptake can enhance T cell responses and growth in vivo as mice transgenically overexpressing the glucose transporter GLUT1 in T cells accumulate effector T cells with age [22,41] and GLUT1 overexpression is correlated with poor prognosis in a variety of cancers [42]. The gene discussed is SLC2A1; the disease is cancer.